Banner Life Sciences
Manufacturing · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3980 Premier Dr Ste 110, High Point, Nor...Phone Number
(336) 899-0959Website
www.bannerls.comRevenue
$21.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Banner Life Sciences
Banner Life Sciences specializes in developing innovative specialty pharmaceuticals aimed at addressing unmet clinical needs. They leverage their formulation expertise and proprietary technologies to create new medicines and enhance existing products. One of their key offerings is BAFIERTAM, a disease-modifying therapy for relapsing forms of multiple sclerosis. Their intended clients include patients suffering from these conditions, as well as healthcare providers seeking effective treatment options.Explore more
Banner Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Banner Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Banner Life Sciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Banner Life Sciences
Banner Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Banner Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Banner Life Sciences had a recent Job posting/layoffs
Product Launch: Get notified when Banner Life Sciences launches new products
Check out if Banner Life Sciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Banner Life Sciences has new funding data
Recommended Actions
Find VP level buyers at Banner Life Sciences
Find 3 more new buyers
Compare Similar Companies to Banner Life Sciences
Compare insights from companies similar to Banner Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Banner Life Sciences
$21.9M
51-200
Private
-
1992
ML
Michael LyttonGroup Executive VP-Corp Development and Strategy and Gen Manager
Company Profile Activity
Activity Insights
Banner Life Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Banner Life Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Banner Life Sciences.
Banner Life Sciences Tech Stack
A closer look at the technologies used by Banner Life Sciences
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Promotion
Executive Move
Erin Ritchie has been promoted from QM BSA II & Applications Lead to Manager, IT Applications.
Executive Moves, Promotion, Application Development
Promotion
Lindsay Fernandez has been promoted from Senior Project Manager, IT, to Director, Business Systems Solutions.
Promotion, Enterprise Software
Project
Banner Life Sciences recently implemented SAP foundation for the Canadian business unit. Bill Bissinger, Chief Information Officer, provided oversight.
Implementation, HRIS, Enterprise Software
Project
Implementation, HRIS, Product Development, Research & Development, Enterprise Software
Banner Life Sciences News & Media
Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment for Relapsing Forms of Multiple Sclerosis, is Now Available in the U.S.
HIGH POINT, N.C.--(BUSINESS WIRE)--Banner Life Sciences announces that BAFIERTAM has commercially launched and is now available in the U.S.Banner Life Sciences Announces Commercial Launch of BAFIERTAM, a Novel Oral Fumarate Treatment for Relapsing Forms of Multiple Sclerosis
HIGH POINT, N.C.--(BUSINESS WIRE)--Banner Life Sciences announces that BAFIERTAMâ„¢ will be commercially available in the U.S. September 1, 2020.Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple Sclerosis
HIGH POINT, N.C.--(BUSINESS WIRE)--Banner Life Sciences announces that the FDA has granted final approval of BAFIERTAMâ„¢ for the treatment of relapsing forms of multiple sclerosisBanner Life Sciences Receives Favorable Appellate Court Decision in Biogen Patent Infringement Dispute
HIGH POINT, N.C.--(BUSINESS WIRE)--Banner Life Sciences receives a favorable appellate court decision in Biogen patent infringement dispute
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Banner Life Sciences
Sign Up For FreeTo access detailed company insights
Banner Life Sciences specializes in developing innovative specialty pharmaceuticals aimed at addressing unmet clinical needs. They leverage their formulation expertise and proprietary technologies to create new medicines and enhance existing products. One of their key offerings is BAFIERTAM, a disease-modifying therapy for relapsing forms of multip... Read More
